Bringing the fundamentals into focus…
Back to Niagen Bioscience, Inc.
How Niagen Bioscience, Inc. stacks up
NAGE · against 798 other Consumer Defensive companies
Valuation
55/ 100
Above the middle of the pack.
Ranked #357 of 799 · scores higher than 55% of peers
Bars: peers in each 10-point band of the valuation score79 peers with a valuation score of 50–59, including NAGE · Click a bar to see the companies
Why valuation scores 55?
Weighted metrics compared with all Consumer Defensive companies.A mix: stronger earnings yield, but weaker free cash flow yield than most Consumer Defensive peers.
- less free cash flow for the price paid: weaker than 73% of peers. Free cash flow yield: 3.0% vs peer median 6.2%
- EBITDA yield is close to the peer norm. EBITDA yield: 7.8% vs peer median 8.7%
- higher earnings for the price paid: stronger than 78% of peers. Earnings yield: 8.6% vs peer median 4.5%
Metric by metric
Position: dot = NAGE, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NAGE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 771 reported | 8.1% | 4.5% | 78% | 30% | |
| EBITDA yieldHigher is better · 812 reported | 7.8% | 8.9% | 42% | 50% | |
| Free cash flow yieldHigher is better · 312 reported | 3.0% | 6.3% | 27% | 20% | |
| Book yieldHigher is better · 767 reported | 44.2% | 54.4% | 41% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around NAGE| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 399.1B KRW (≈$287M) | 100 | 72 | |
| 1 | 242.6B KRW (≈$175M) | 100 | 70 | |
| 1 | 3.6B MYR (≈$796M) | 100 | 82 | |
| 1 | 101M SGD (≈$77M) | 100 | 89 | |
| 5 | 456M HKD (≈$58M) | 98 | 70 | |
| 357 | 539.4B JPY (≈$3.7B) | 55 | 51 | |
| 357 | 44.5B JPY (≈$303M) | 55 | 47 | |
| 357 | 717.6B BRL (≈$129.2B) | 55 | 59 | |
| 357 | 2.6B EUR (≈$2.9B) | 55 | 34 | |
| 357 | 187M USD | 55 | 78 | |
| 357 | 2.7B CAD (≈$2.0B) | 55 | 54 | |
| 357 | 94.2B NOK (≈$9.0B) | 55 | 63 | |
| 365 | 10.0B CNY (≈$1.4B) | 54 | 39 | |
| 365 | 617.4B JPY (≈$4.2B) | 54 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score